Step Therapy For Anti-Inflammatories, ESAs Coming To UnitedHealthcare Medicare Plans

 
• By Cathy Kelly

Remicade, Procrit, Aranesp and biosimilars will be subject to step therapy in limited number of Medicare Advantage plans in 2019.

Elderly man with walking frame going up the stairs outdoors

More from Pricing Debate

More from Market Access